Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives
- First Online:
- Cite this article as:
- Zhao, Y., Zhang, A., Du, H. et al. Rheumatol Int (2012) 32: 837. doi:10.1007/s00296-011-2133-2
- 406 Downloads
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by the influxation of synovia and synovial compartments with immune cells including dendritic cells (DCs). DCs that induce autoimmune tolerance are called tolerogenic DCs (tolDCs). As a promising immunotherapeutic strategy for RA, tolDCs have received increasing attention. In this review, we first introduce the significant role of tolDCs in autoimmune regulation and then describe the manipulation strategies to generate tolDCs; next, we summarize recent progress in the experimental application of tolDCs for RA therapy, and finally we discuss the perspectives of tolerogenic vaccination for the treatment for RA in clinic.